NUWE
Nuwellis IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$1.78M
P/E Ratio
—
EPS
$-26.89
Beta
0.17
52W High
$16.50
52W Low
$0.13
50-Day MA
$0.94
200-Day MA
$2.23
Dividend Yield
—
Profit Margin
-214.90%
Forward P/E
—
PEG Ratio
—
About Nuwellis Inc
Nuwellis, Inc., a medical device company, focuses on the development, manufacture and marketing of medical devices used in ultrafiltration therapy. The company is headquartered in Eden Prairie, Minnesota.
Fundamentals
| Revenue (TTM) | $8.77M |
| Gross Profit (TTM) | $5.74M |
| EBITDA | $-12.25M |
| Operating Margin | -181.70% |
| Return on Equity | -584.00% |
| Return on Assets | -109.50% |
| Revenue/Share (TTM) | $7.41 |
| Book Value | $1.09 |
| Price-to-Book | 0.67 |
| Price-to-Sales (TTM) | 0.20 |
| EV/Revenue | 0.0146 |
| EV/EBITDA | -0.34 |
| Quarterly Earnings Growth (YoY) | -99.20% |
| Quarterly Revenue Growth (YoY) | 26.20% |
| Shares Outstanding | $12.75M |
| Float | $1.54M |
| % Insiders | 0.22% |
| % Institutions | 2.33% |
Historical Volatility
HV 10-Day
167.85%
HV 20-Day
131.42%
HV 30-Day
114.55%
HV 60-Day
94.81%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($11.00 target)
1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026